- Home
- LICN vs NDRA Comparison
LICN vs NDRA Comparison
Compare LICN & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICN
- NDRA
- Stock Information
- Founded
- LICN 2004
- NDRA 2007
- Country
- LICN China
- NDRA United States
- Employees
- LICN N/A
- NDRA N/A
- Industry
- LICN
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LICN
- NDRA Health Care
- Exchange
- LICN Nasdaq
- NDRA Nasdaq
- Market Cap
- LICN 2.1M
- NDRA 2.3M
- IPO Year
- LICN 2023
- NDRA 2017
- Fundamental
- Price
- LICN $4.92
- NDRA $3.35
- Analyst Decision
- LICN
- NDRA Strong Buy
- Analyst Count
- LICN 0
- NDRA 1
- Target Price
- LICN N/A
- NDRA $46.00
- AVG Volume (30 Days)
- LICN 1.7M
- NDRA 102.3K
- Earning Date
- LICN 01-01-0001
- NDRA 05-15-2025
- Dividend Yield
- LICN N/A
- NDRA N/A
- EPS Growth
- LICN N/A
- NDRA N/A
- EPS
- LICN N/A
- NDRA N/A
- Revenue
- LICN $41,477,000.00
- NDRA N/A
- Revenue This Year
- LICN N/A
- NDRA N/A
- Revenue Next Year
- LICN N/A
- NDRA N/A
- P/E Ratio
- LICN N/A
- NDRA N/A
- Revenue Growth
- LICN 4.32
- NDRA N/A
- 52 Week Low
- LICN $2.60
- NDRA $2.90
- 52 Week High
- LICN $488.00
- NDRA $577.50
- Technical
- Relative Strength Index (RSI)
- LICN 49.93
- NDRA 43.80
- Support Level
- LICN $5.61
- NDRA $2.92
- Resistance Level
- LICN $6.16
- NDRA $3.30
- Average True Range (ATR)
- LICN 1.10
- NDRA 0.25
- MACD
- LICN -0.11
- NDRA -0.04
- Stochastic Oscillator
- LICN 40.85
- NDRA 75.00
About LICN Lichen China Limited
Lichen International Ltd formerly Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.